We’re excited to share that Dr. Victoria Villaflor from City of Hope is one of the first to activate Tempus’ Phoenix study. Phoenix is a multi-institutional, biomarker profiling study in front line metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). As part of the study, enrolled patients will undergo molecular testing at various points throughout their journey, from metastatic diagnosis through progression, to support research for HNSCC. Learn more: https://tempus.co/Phoenix
Yea, Dr Villaflor
Retired photographer at GVR's videos
1moWell done!